Jolyon Dales

2.7k total citations
10 papers, 229 citations indexed

About

Jolyon Dales is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Social Psychology. According to data from OpenAlex, Jolyon Dales has authored 10 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Social Psychology. Recurrent topics in Jolyon Dales's work include Diabetes Treatment and Management (3 papers), Mental Health Treatment and Access (2 papers) and Diabetes Management and Research (2 papers). Jolyon Dales is often cited by papers focused on Diabetes Treatment and Management (3 papers), Mental Health Treatment and Access (2 papers) and Diabetes Management and Research (2 papers). Jolyon Dales collaborates with scholars based in United Kingdom, Italy and Germany. Jolyon Dales's co-authors include Dinesh Bhugra, Melanie J. Davies, Kamlesh Khunti, Meryam Schouler‐Ocak, Alex Till, Adil Qureshi, Susham Gupta, Driss Moussaoui, Mauro Giovanni Carta and Ilaria Tarricone and has published in prestigious journals such as Annals of Oncology, Canadian Medical Association Journal and Diabetes Obesity and Metabolism.

In The Last Decade

Jolyon Dales

8 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolyon Dales United Kingdom 7 104 69 54 51 46 10 229
Gemma Traviss‐Turner United Kingdom 10 155 1.5× 48 0.7× 27 0.5× 54 1.1× 46 1.0× 24 306
Samineh Sanatkar Australia 9 52 0.5× 92 1.3× 60 1.1× 47 0.9× 41 0.9× 31 230
Dhana Ratna Shakya Nepal 10 132 1.3× 41 0.6× 52 1.0× 14 0.3× 24 0.5× 80 289
Ramyadarshni Vadivel New Zealand 6 73 0.7× 27 0.4× 33 0.6× 18 0.4× 12 0.3× 8 170
Sue Bellass United Kingdom 9 48 0.5× 92 1.3× 37 0.7× 43 0.8× 59 1.3× 25 251
Mary C. Vance United States 8 108 1.0× 67 1.0× 33 0.6× 16 0.3× 6 0.1× 20 236
Tomoko Udo United States 12 227 2.2× 51 0.7× 32 0.6× 62 1.2× 12 0.3× 15 357
Seyedmohammad Mirhosseini Iran 9 120 1.2× 45 0.7× 41 0.8× 54 1.1× 9 0.2× 46 235
Sara Bartel Canada 8 103 1.0× 31 0.4× 19 0.4× 31 0.6× 18 0.4× 24 261
Kangkan Pathak India 5 80 0.8× 32 0.5× 79 1.5× 20 0.4× 9 0.2× 12 188

Countries citing papers authored by Jolyon Dales

Since Specialization
Citations

This map shows the geographic impact of Jolyon Dales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolyon Dales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolyon Dales more than expected).

Fields of papers citing papers by Jolyon Dales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolyon Dales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolyon Dales. The network helps show where Jolyon Dales may publish in the future.

Co-authorship network of co-authors of Jolyon Dales

This figure shows the co-authorship network connecting the top 25 collaborators of Jolyon Dales. A scholar is included among the top collaborators of Jolyon Dales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolyon Dales. Jolyon Dales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Péchoux, C. Le, Nathalie Cozic, Erik Bouvier, et al.. (2025). 1795P SMARC4, c-MET and PD-L1 expression in pN2 non-small cell lung cancer from LungART IFCT 0503 trial. Annals of Oncology. 36. S974–S974.
2.
Dales, Jolyon, et al.. (2024). Co-existence of type 1 diabetes and monogenic diabetes in one family: getting the diagnosis right. British Journal of Diabetes. 24(1). 108–110.
3.
4.
Webb, David R., Jolyon Dales, Francesco Zaccardi, et al.. (2018). Intensive versus standard multifactorial cardiovascular risk factor control in screen‐detected type 2 diabetes: 5‐year and longer‐term modelled outcomes of the ADDITION‐Leicester study. Diabetes/Metabolism Research and Reviews. 35(3). e3111–e3111. 10 indexed citations
5.
Zaccardi, Francesco, Nafeesa Dhalwani, Jolyon Dales, et al.. (2017). Comparison of glucose‐lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 20(4). 985–997. 25 indexed citations
6.
Bhugra, Dinesh, Norman Sartorius, Andrea Fiorillo, et al.. (2015). EPA guidance on how to improve the image of psychiatry and of the psychiatrist. European Psychiatry. 30(3). 423–430. 26 indexed citations
7.
Bhugra, Dinesh, Antonio Ventriglio, Martina Rojnić Kuzman, et al.. (2015). EPA guidance on the role and responsibilities of psychiatrists. European Psychiatry. 30(3). 417–422. 23 indexed citations
8.
Gray, Laura J., Jolyon Dales, Emer M. Brady, et al.. (2015). Safety and effectiveness of non‐insulin glucose‐lowering agents in the treatment of people with type 2 diabetes who observe R amadan: a systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 17(7). 639–648. 32 indexed citations
9.
Bhugra, Dinesh, Susham Gupta, Meryam Schouler‐Ocak, et al.. (2014). EPA Guidance Mental Health Care of Migrants. European Psychiatry. 29(2). 107–115. 102 indexed citations
10.
Dales, Jolyon. (2005). Delisting chiropractic and physiotherapy: False saving?. Canadian Medical Association Journal. 172(2). 166–166. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026